1 Updates

Lead Discovery Center GmbH Announces Five-Year Strategic Partnership with Merck Serono

Nov 2 2013, 3:18am CDT | by PR.com

Partners will collaborate to discover lead structures and potential development candidates for novel drug targets.

Dortmund, Germany, November 02, 2013 --(PR.com)-- Lead Discovery Center GmbH (LDC) a renowned translational research organization, today announced a five-year strategic partnership with Merck...

Filed under: news

Full Story below YouTube Videos

 
 

 

24 weeks ago

Lead Discovery Center GmbH Announces Five-Year Strategic Partnership with Merck Serono

Nov 2 2013, 3:18am CDT | by PR.com

Partners will collaborate to discover lead structures and potential development candidates for novel drug targets.

Dortmund, Germany, November 02, 2013 --(PR.com)-- Lead Discovery Center GmbH (LDC) a renowned translational research organization, today announced a five-year strategic partnership with Merck Serono, Darmstadt, Germany, the biopharmaceutical division of Merck. This collaboration integrates the expertise and resources of both organizations to expedite the discovery of promising lead structures and to optimize the development of therapeutic candidates in areas of high unmet medical need.

Under the terms of this agreement, Merck Serono and LDC will enter into a broader drug discovery collaboration aiming to identify lead candidates to multiple drug targets. Merck Serono hereby expands a successful initial collaboration with LDC in oncology into a strategic partnership spanning across all of Merck Serono's core research and development areas. The first project under the new agreement will be in immunology and emerged from an ongoing collaboration of LDC with the Max-Planck researcher and Nobel Laureate Prof. Robert Huber.

"Merck Serono is a recognized leader in drug discovery and development with a strong research base in Germany and shares our rigorous approach to pursuing the most promising lead candidates," said Dr. Bert Klebl, Managing Director of LDC. "We are excited to extend our collaboration with Merck Serono into a strategic alliance combining our complementary expertise to translate academic research into promising drug candidates at an accelerated rate, and with a greater chance of therapeutic success."

"This partnership is a key element of our strategy to access alliances with leading partners to enhance our pipeline of novel targets and drug candidates," said Dr. Susan Jane Herbert, Executive Vice President, Head of Business Development and Strategy at Merck Serono. "We are confident that the combination of LDC's strong academic network and high innovation potential in chemical optimization and screening, combined with the drug development and clinical trial expertise of Merck Serono, has the potential to accelerate our joint development of new therapies in areas of high unmet medical needs."

Both organizations will contribute expertise, infrastructure and resources to identify lead candidates and will work closely together in interdisciplinary project teams to advance them into pharmaceutical leads. More specifically, LDC will drive the design, screening and synthesis of compounds during discovery phases, while Merck Serono will provide extended in vitro and in vivo pharmacological profiling, scale up, pre-clinical and pharmacokinetics as well as clinical study design expertise. Merck Serono will be responsible for drug development and commercialization for selected drug candidates. Under the terms of the agreement, LDC will receive research funding, and for selected drug candidates, milestone and royalty payments. Further financial details of the agreement are not disclosed.

About LDC Dortmund

The Lead Discovery Center (LDC) was established in 2008 by the technology transfer organization Max Planck Innovation, as a novel approach to capitalize on the potential of excellent basic research for the discovery of new therapies for diseases with high medical need.

LDC takes on promising early-stage projects from academia and transforms them into innovative pharmaceutical leads that reach initial proof-of-concept in animals. In close collaboration with high profile partners from academia and industry, LDC is building a strong and growing portfolio of small molecule leads with exceptional medical and commercial potential. LDC sustains a preferred partnership with the Max Planck Society and has formed alliances with AstraZeneca, Bayer and Merck Serono as well as leading academic drug discovery centers around the globe. Further information at: www.lead-discovery.de

Contact Information:
Lead Discovery Center GmbH
Thomas Hegendörfer
4923197427002
Contact via Email
http://www.lead-discovery.de/
Otto-Hahn-Straße 15
Dortmund
Germany

Read the full story here: http://www.pr.com/press-release/525214

Press Release Distributed by PR.com

Source: PR.com

 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

Precision Door Service of the Bay Area California Has New Owners
San Jose, CA, April 21, 2014 --(PR.com)-- Congratulations to Pat and Amie Prendergast, the new owners of Precision Door Service of the Bay Area, California. This location originally opened in 2001, and proudly serves...
 
 
Celebrity Hairstylist Julien Farel Debuts First-Of-Its-Kind Power Beauty Menu at Loews Regency Hotel
Celebrity Hairstylist Julien Farel Debuts First-Of-Its-Kind Power Beauty Menu at Loews Regency Hotel
New York, NY, April 21, 2014 --(PR.com)-- Julien Farel, luxury hairstylist and entrepreneur, brings ‘Power Beauty’ to the home of the legendary Power Breakfast. Farel, with over 30 years of experience and...
 
 
Honorable Judge Theodore R. Essex to speak at International Intellectual Property Law Association (IIPLA) Annual Congress 2015
Dubai, United Arab Emirates, April 21, 2014 --(PR.com)-- Administrative Law Judge, United States International Trade Commission, Honorable Theodore R. Essex will speak at International Intellectual Property Law...
 
 
Wealth DNA Radio Show Discusses MyRA’s and GRA’s vs IRA’s and 401(k) plans with Teresa Ghilarducci, PhD on April 28, 2014 at 9:00 AM PDT
Wealth DNA Radio Show Discusses MyRA’s and GRA’s vs IRA’s and 401(k) plans with Teresa Ghilarducci, PhD on April 28, 2014 at 9:00 AM PDT
The Wealth DNA radio show will have Teresa Ghilarducci, PhD as the featured guest on April 28, 2014 at 9:00 AM PDT (12 noon EDT). The show will focus on MyRA's and GRA's vs. IRA's and 401(k) plans.
 
 
 

Latest from the Network

Precision Door Service of the Bay Area California Has New Owners
San Jose, CA, April 21, 2014 --(PR.com)-- Congratulations to Pat and Amie Prendergast, the new owners of Precision Door Service of the Bay Area, California. This location originally opened in 2001, and proudly serves...
Read more on Business Balla
 
Celebrity Hairstylist Julien Farel Debuts First-Of-Its-Kind Power Beauty Menu at Loews Regency Hotel
New York, NY, April 21, 2014 --(PR.com)-- Julien Farel, luxury hairstylist and entrepreneur, brings ‘Power Beauty’ to the home of the legendary Power Breakfast. Farel, with over 30 years of experience and...
Read more on Business Balla
 
Honorable Judge Theodore R. Essex to speak at International Intellectual Property Law Association (IIPLA) Annual Congress 2015
Dubai, United Arab Emirates, April 21, 2014 --(PR.com)-- Administrative Law Judge, United States International Trade Commission, Honorable Theodore R. Essex will speak at International Intellectual Property Law...
Read more on Business Balla
 
Wealth DNA Radio Show Discusses MyRA’s and GRA’s vs IRA’s and 401(k) plans with Teresa Ghilarducci, PhD on April 28, 2014 at 9:00 AM PDT
Phoenix, AZ, April 21, 2014 --(PR.com)-- The MyRA (My Retirement Account) was just announced during the 2014 State of the Union address, as a new vehicle for retirement saving. A key feature is that participants will...
Read more on Politics Balla
 
Wealth DNA Radio Show Discusses MyRA’s and GRA’s vs IRA’s and 401(k) plans with Teresa Ghilarducci, PhD on April 28, 2014 at 9:00 AM PDT
Phoenix, AZ, April 21, 2014 --(PR.com)-- The MyRA (My Retirement Account) was just announced during the 2014 State of the Union address, as a new vehicle for retirement saving. A key feature is that participants will...
Read more on Business Balla
 
Gold Star Mortgage Financial Group, Corporation Names Dan Sugg President
Ann Arbor, MI, April 21, 2014 --(PR.com)-- Gold Star Mortgage Financial Group, Corp, one of the nation’s premiere mortgage companies, names lending industry veteran Dan Sugg President. Mr. Sugg will be based at...
Read more on Business Balla
 
Pre-Owned Medical Devices Market is Expected to Reach USD 4.9 Billion Globally in 2019: Transparency Market Research
Albany, NY, April 21, 2014 --(PR.com)-- The Pre-Owned Medical Devices Market was valued at USD 2.4 billion in 2012 and is expected to grow at a CAGR of 10.6% from 2013 to 2019, to reach an estimated value of USD 4.9...
Read more on Business Balla
 
CrucialClicks.com, Hires Karina Tama as Social Media Manager
Coral Springs, FL, April 21, 2014 --(PR.com)-- CrucialClicks.com announces the hiring of Karina Tama as Social Media Manager. Karina is responsible for developing, implementing, tracking and optimizing CrucialClicks....
Read more on Business Balla
 
CrucialClicks.com, Hires Karina Tama as Social Media Manager
Coral Springs, FL, April 21, 2014 --(PR.com)-- CrucialClicks.com announces the hiring of Karina Tama as Social Media Manager. Karina is responsible for developing, implementing, tracking and optimizing CrucialClicks....
Read more on Ad Balla
 
Rugknots Launches E-commerce Site, Contributes 2% of All Rug Purchases to Children's Education
Washington, DC, April 21, 2014 --(PR.com)-- RugKnots a leading producer of high-quality handmade oriental designer rugs, has now launched an e-commerce site making their handcrafted designer rugs available to...
Read more on Business Balla
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla